Tagrisso Side Effects
Generic Name: osimertinib
Note: This page contains side effects data for the generic drug osimertinib. It is possible that some of the dosage forms included below may not apply to the brand name Tagrisso.
Common side effects of Tagrisso include: cough. See below for a comprehensive list of adverse effects.
For the Consumer
Applies to osimertinib: oral tablet
As well as its needed effects, osimertinib (the active ingredient contained in Tagrisso) may cause unwanted side effects that require medical attention.
Major Side Effects
If any of the following side effects occur while taking osimertinib, check with your doctor immediately:More common:
- dizziness, lightheadedness, or fainting
- eye or vision changes
- fast, pounding, or uneven heartbeat
- pain in the chest, groin, or legs, especially the calves
- pain, redness, or swelling in the arm or leg
- shortness of breath or troubled breathing
- slurred speech
- sudden loss of coordination
- sudden, severe headache
- sudden, severe weakness or numbness in the arm or leg
- Blurred vision
- fever or chills
- general feeling of discomfort or illness
- inability to speak
- sore throat
- sudden, severe weakness on one side of the body
- temporary blindness
- thickening of bronchial secretions
Minor Side Effects
Some osimertinib side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:More common:
- Back pain
- changes in the fingernails or toenails, including brittleness, inflammation, pain, redness, tenderness, separation from nail bed, or shedding of nails
- decreased appetite
- skin rash, dryness, or itching
- swelling or inflammation of the mouth
- unusual tiredness or weakness
For Healthcare Professionals
Applies to osimertinib: oral tablet
-The most common (more than 30%) adverse reactions were lymphopenia, thrombocytopenia, anemia, diarrhea, rash, neutropenia, and dry skin.
-1% or less of patients developed fatal adverse reactions of interstitial lung disease (ILD)/pneumonitis, pneumonia, and cerebrovascular accident (CVA)/cerebral hemorrhage.[Ref]
Very common (10% or more): Lymphopenia (63%), thrombocytopenia (54%), anemia (44%), neutropenia (33%)[Ref]
Very common (10% or more): Diarrhea (42%), nausea (17%), decreased appetite (16%), constipation (15%), stomatitis (12%)[Ref]
Very common (10% or more): Rash (41%), dry skin (31%), nail toxicity (25%), pruritus (14%)[Ref]
-Rash cases included various types of rash (generalized, erythematous, macular, maculo-papular, papular, pustular), erythema, folliculitis, acne, dermatitis, and acneform dermatitis.
-Dry skin included eczema, skin fissures, and xerosis.
-Nail toxicity included nail and nail bed disorders, nail bed inflammation, nail bed tenderness, nail discoloration, nail dystrophy, nail infection, nail ridging, onychoclasis, onycholysis, onychomadesis, and paronychia.[Ref]
Very common (10% or more): Hyponatremia (26%), hypermagnesemia (20%)[Ref]
Eye disorders included dry eye, blurred vision, keratitis, cataract, eye irritation, blepharitis, eye pain, increased lacrimation, and vitreous floaters.[Ref]
Very common (10% or more): Eye disorders (18%)
Uncommon (0.1% to 1%): Other ocular toxicities[Ref]
Very common (10% or more): Cough (14%)
Common (1% to 10%): ILD/pneumonitis, pneumonia[Ref]
Venous thromboembolism included cases of deep vein thrombosis, jugular venous thrombosis, and pulmonary embolism.[Ref]
Very common (10% or more): Fatigue (14%)
Common (1% to 10%): Venous thromboembolism[Ref]
Very common (10% or more): Back pain (13%)[Ref]
Very common (10% or more): Headache (10%)
Common (1% to 10%): CVA/cerebral hemorrhage[Ref]
Common (1% to 10%): Cardiomyopathy
Frequency not reported: QTc interval prolongation[Ref]
1. "Product Information. Tagrisso (osimertinib)." Astra-Zeneca Pharmaceuticals, Wilmington, DE.
It is possible that some side effects of Tagrisso may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.
More about Tagrisso (osimertinib)
Related treatment guides
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.